The Effects on Sleep qualıty and fatıgue Level of Foot Bath
Chronic Obstructive Pulmonary Disease
About this trial
This is an interventional supportive care trial for Chronic Obstructive Pulmonary Disease focused on measuring COPD, fatigue, foot bath, nursing, sleep quality
Eligibility Criteria
Inclusion Criteria: The patients, who were diagnosed with COPD, were aged between 55-85 years, did not have a psychiatric disease requiring treatment, had no diagnosed sleep disorder, had orientation to person, place, and time, can be communicated verbally, had a general state of health enough to perceive the questions in the questionnaire and answer them correctly, had a mild (FEV1 ≥ 80%) and moderate (50% ≤ FEV1 < 80%) COPD stage, agreed to participate in the study were included in the study. Exclusion Criteria: The patients, who had Diabetes Mellitus (DM), CVA, CHF, coronary artery disease, coagulation disorders such as varicosity, deep vein thrombosis and disseminated intravascular coagulation, were using CPAP (Continuous Positive Airway Pressure) and BIPAP (Bi-level Positive Airway Pressure) devices, were diagnosed with sleep disorder, had the general condition disorder developed related to diagnosis within the application and control process were excluded from the study.
Sites / Locations
- Sevil Şahin
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intervention
Control
foot bath is a type of relaxation and care performed by putting feet in water. Feet, as the organs carrying the whole body weight are the body parts where fatigue is felt most. In this study, a specially designed foot bath bucket was used in order to apply foot bath for the patients in the experimental group. The bucket has a five-level water heating system (35-48 °C). It has a magnetic field and operates at 390 Watt. It has a splash shield. There are non-slip rubber legs on its bottom. it has heat protection feature for thermal insulation as it has a two-walled structure
On the first day (the first follow-up), Patient Information Form, PSQI (ANNEX-II) and Piper Fatigue Scale were applied to the patients in the control group whose consent was obtained in the first follow-up, through face-to-face interview. At the end of the 30th day (the second follow-up), PSQI and Piper Fatigue Scale were applied again to the patients who came for the outpatient clinic control. The routine treatment of the control group was not interfered and no intervention was performed.